EZH2 and hepatocellular carcinoma: Several reports have noted that EZH2 was over-expressed in most HCC resection tissues by immunohistochemistry, whereas it was negatively expressed in nearly all of the corresponding non-tumor tissues [14], [15], which was consistent with our findings.